These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 750970)

  • 21. HIV infection in multi-transfused thalassemic children.
    Kumar S; Agnihotri SK; Marwaha RK; Sehgal S
    Indian Pediatr; 1994 Nov; 31(11):1438-40. PubMed ID: 7896354
    [No Abstract]   [Full Text] [Related]  

  • 22. Growth velocity in transfusion dependent prepubertal thalassemia patients: results from a thalassemia center in Malaysia.
    Hamidah A; Arini MI; Zarina AL; Zulkifli SZ; Jamal R
    Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):900-5. PubMed ID: 19058587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron chelating therapy in thalassemia: current problems.
    Russo G
    Haematologica; 1990; 75 Suppl 5():84-8. PubMed ID: 2086385
    [No Abstract]   [Full Text] [Related]  

  • 24. [Neurologic pathology in subjects with beta-thalassemia major].
    Incorpora G; Romeo MA; Inì G; Pizzarelli G; Di Gregorio F
    Minerva Pediatr; 1988 Jan; 40(1):41-6. PubMed ID: 3374452
    [No Abstract]   [Full Text] [Related]  

  • 25. Thalassaemia in Australia.
    Turner E
    Aust Paediatr J; 1973 Feb; 9(1):3-4. PubMed ID: 4708027
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation of the diastolic phase of the left ventricle, using the apex cardiogram, in patients with thalassemia major].
    Roncon L; Sartorelli L; Fiorencis R; Canova C; Zanazzi G; Cichella E; Pizzardo A; Zonzin P
    G Clin Med; 1983 Nov; 64(11):420-7. PubMed ID: 6667797
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evaluation of the dynamics of the blood platelets in polytransfused subjects of pediatric age].
    Mensi E
    Minerva Nipiol; 1968; 18():Suppl 6:397+. PubMed ID: 5266942
    [No Abstract]   [Full Text] [Related]  

  • 28. [Post-transfusion multiple isoantibodies in a girl with thalassemia major].
    Centa A; Marchi AG
    Minerva Pediatr; 1968 Mar; 20(10):518-21. PubMed ID: 5739011
    [No Abstract]   [Full Text] [Related]  

  • 29. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
    Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD
    Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of iron overload in thalassemia.
    Piomelli S; Graziano J
    Birth Defects Orig Artic Ser; 1982; 18(7):339-46. PubMed ID: 7159742
    [No Abstract]   [Full Text] [Related]  

  • 31. Bone marrow transplantation in thalassemia.
    Lucarelli G; Giardini C; Baronciani D
    Semin Hematol; 1995 Oct; 32(4):297-303. PubMed ID: 8560287
    [No Abstract]   [Full Text] [Related]  

  • 32. [Incidence of Australia antigen (HB Ag) and its related antibody (HB Ab) in Siciliam thalassemic children treated with multiple transfusions].
    Musumeci S; Di Gregorio F; Marino S; Fischer A; Pizzarelli G
    Pediatria (Napoli); 1977 Mar; 85(1):21-33. PubMed ID: 876745
    [No Abstract]   [Full Text] [Related]  

  • 33. [The endocrine complications in thalassemia major].
    Anastasi S; Caruso V; Magnano C; Leocata A
    Pediatr Med Chir; 1991; 13(1):63-5. PubMed ID: 2052458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The Milan experience in screening for hemoglobinopathies].
    Morganti G; Gualandri V; Orsini GB
    Minerva Med; 1981 Mar; 72(11):696-700. PubMed ID: 7243016
    [No Abstract]   [Full Text] [Related]  

  • 35. [Biosynthesis of hemoglobin in beta-thalassemia major. Data from patients at the pediatric department of the University of Naples].
    Esposito L; Ferrara M; Ponte G
    Pediatria (Napoli); 1978 Sep; 86(3):361-74. PubMed ID: 754157
    [No Abstract]   [Full Text] [Related]  

  • 36. [The treatment of intermediate thalassemia].
    Cacciola E
    Haematologica; 1989 Oct; 74(5 Suppl):252-65. PubMed ID: 2480271
    [No Abstract]   [Full Text] [Related]  

  • 37. Haptoglobin status in thalassemia.
    Tharthare MK; Baxi AJ; Chengappa D
    Indian Pediatr; 1984 Mar; 21(3):223-7. PubMed ID: 6490143
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of desferrioxamine B in the treatment of post-transfusion hypersiderosis].
    Orsini A; Giraud F; Bernard P; Passeron P
    Mars Med; 1965; 102(7):591-5. PubMed ID: 5855127
    [No Abstract]   [Full Text] [Related]  

  • 39. The management of beta-thalassemia in an urban district hospital.
    Lyn PC; Teh HC; Mulvey RF
    Med J Malaysia; 1985 Mar; 40(1):3-10. PubMed ID: 3831730
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinico-therapeutic findings on diabetic complications in thalassemia].
    Colli G; Mariani D; Boffa C; Merisio MG; Terzoli S; Colleoni C; Stucchi C; Biella CA
    Pediatr Med Chir; 1984; 6(6):765-7. PubMed ID: 6545586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.